| Code | CSB-RA003996MB3HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to VIS-954, developed for research applications targeting C5AR1 (Complement Component 5a Receptor 1), also known as CD88. C5AR1 is a G protein-coupled receptor that binds the complement activation fragment C5a, playing a critical role in innate immune responses and inflammatory signaling. Upon C5a binding, C5AR1 triggers downstream pathways that promote neutrophil chemotaxis, degranulation, and pro-inflammatory cytokine release. Dysregulated C5AR1 signaling has been implicated in various pathological conditions, including sepsis, acute respiratory distress syndrome, autoimmune disorders, neurodegenerative diseases, and cancer, where it can influence tumor microenvironment dynamics and immune evasion.
VIS-954 represents a therapeutic antibody designed to modulate C5AR1 activity, making this biosimilar a valuable tool for investigating complement-mediated inflammation and immune responses. This antibody enables researchers to explore C5AR1 function in disease models, evaluate complement system involvement in pathological processes, and support preclinical studies examining anti-inflammatory therapeutic strategies. It serves as an essential reagent for advancing understanding of complement biology and C5AR1-targeted interventions.
There are currently no reviews for this product.